Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 2
Submit an article Journal homepage
340
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Positivity thresholds of HbA1c assay as a screening test for diabetes mellitus in the first trimester in high-risk populations

Allison R. WalkerDepartment of Obstetrics and Gynecology, Oregon Health and Sciences University, Portland, OR, USAORCID Iconhttps://orcid.org/0000-0001-6865-2556
ORCID Icon &
Aaron B. CaugheyDepartment of Obstetrics and Gynecology, Oregon Health and Sciences University, Portland, OR, USACorrespondence[email protected]
Pages 230-234 | Received 08 May 2018, Accepted 11 Jan 2020, Published online: 09 Mar 2020

References

  • Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183–1197. https://care.diabetesjournals.org/content/39/Supplement_1/S13
  • DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010. Prev Chronic Dis. 2014;11:E104.
  • Bell R, Bailey K, Cresswell T, et al. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG. 2008;115(4):445–452.
  • Albrecht SS, Kuklina EV, Bansil P, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994–2004. Diabetes Care. 2010;33(4):768–773.
  • Kaaja R, Rönnemaa T. Gestational diabetes: pathogenesis and consequences to mother and offspring. Rev Diabet Stud. 2008;5(4):194–202.
  • American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(Suppl. 1):S13–S22.
  • Mission JF, Ohno MS, Cheng YW, et al. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol. 2012;207(4):326.e1–326.e9.
  • Sweeting AN, Ross GP, Hyett J, et al. Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care. 2016;39(1):75–81.
  • Allen AJ, Snowden JM, Lau B, et al. Type-2 diabetes mellitus: does prenatal care affect outcomes? J Matern Fetal Neonat Med. 2017;31:1–15.
  • Hughes RC, Moore MP, Gullam JE, et al. An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37(11):2953–2959.
  • Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486.
  • Esakoff TF, Cheng YW, Sparks TN, et al. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol. 2009;200(6):672.e1–672.e4.
  • United State Bureau of Labor and Statistics. Consumer Price Indices Database. Washington (DC): Division of Consumer Prices and Price; 2015.
  • Khalafallah A, Phuah E, Al-Barazan AM, et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open. 2016;6(4):e011059.
  • Gillespie P, Cullinan J, O'Neill C, et al. Modeling the independent effects of gestational diabetes mellitus on maternity care and costs. Diabetes Care. 2013;36(5):1111–1116.
  • Kuppermann M, Nease RF, Learman LA, et al. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women’s preferences. Obstet Gynecol. 2000;96(4):511–516.
  • Grobman WA, Dooley SL, Welshman EE, et al. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff? Prenat Diagn. 2002;22(13):1195–1200.
  • Carroll AE, Downs SM. Comprehensive cost-utility analysis of newborn screening strategies. Pediatrics. 2006;117(Suppl. 3):S287–S295.
  • Tam WH, Ma RCW, Ozaki R, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40(5):679–686.
  • Moss JR, Crowther CA, Hiller JE, et al. Costs and consequences of treatment for mild gestational diabetes mellitus – evaluation from the ACHOIS randomised trial. BMC Preg Childbirth. 2007;7:27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.